Which Is the Bigger Story for BioNTech -- Its Colorectal Cancer Vaccine Setback or the Lung Cancer Clinical Success?

BioNTech recently experienced a clinical trial failure, followed by a clinical success several weeks later. The company's deep pipeline could enable it to launch brand-new, lucrative products over the next few years.